A scientist working on drug screening is interesting in two things: first, to know whether the drug candidate is effective against cancer cells, and secondly, to understand the way the drug is killing cancer cells.
There is hope indeed, but only for those patients who have enough time to wait. Developing a new drug is an expensive and time-consuming process made even more difficult by today’s global recession.
A subject often overlooked in the classroom, chemistry will be back on the map through a series of events directly coordinated by Cefic – the European Chemical Industry Council – its member federations from throughout Europe and its member companies. Cefic activities include Xperimania, an educational programme organised with the body representing ministries of education… » read more
Professor Rengul Cetin-Atalay is a passionate researcher of Bilkent University’s Genetics and Molecular Biology Department.The researchers at Bilkent University focus on screening possible drug candidates for liver cancer.